SpyGlass Pharma, Inc. APIC, Share-based Payment Arrangement, Increase for Cost Recognition
SpyGlass Pharma, Inc. (SGP) reported APIC, Share-based Payment Arrangement, Increase for Cost Recognition of $2.08 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue · last filed 2026-08-06
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-06-30 was $2.08M, a 255.20% increase year-over-year.
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2026-03-31 was $1.68M, a 385.51% increase year-over-year.
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-06-30 was $587.00K.
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for the quarter ending 2025-03-31 was $345.00K.
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2025 was $2.79M, a 86.98% increase from fiscal 2024.
- SpyGlass Pharma, Inc. apic, share-based payment arrangement, increase for cost recognition for fiscal 2024 was $1.49M.
| Period end | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 3 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 6 month | APIC, Share-based Payment Arrangement, Increase for Cost Recognition 12 month |
|---|---|---|---|
| 2026-06-30 | $2.08M 10-Q · filed 2026-08-06 | $3.76M derived: sum of 2 quarters · filed 2026-08-06 | |
| 2026-03-31 | $1.68M 10-Q · filed 2026-08-06 | ||
| 2025-12-31 | $2.79M 10-K · filed 2026-03-26 | ||
| 2025-06-30 | $587.00K 10-Q · filed 2026-08-06 | $932.00K derived: sum of 2 quarters · filed 2026-08-06 | |
| 2025-03-31 | $345.00K 10-Q · filed 2026-08-06 | ||
| 2024-12-31 | $1.49M 10-K · filed 2026-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |